Affordable Access

deepdyve-link
Publisher Website

Differences in Chemical Component and Anticancer Activity of Green and Ripe Forsythiae Fructus.

Authors
  • Bao, Jiaolin1
  • Ding, Ren-Bo2
  • Liang, Yeer1
  • Liu, Fang1
  • Wang, Kai1
  • Jia, Xuejing1
  • Zhang, Chao1
  • Chen, Meiwan1
  • Li, Peng1
  • Su, Huanxing1
  • Wan, Jian-Bo1
  • Wang, Yitao1
  • He, Chengwei1
  • 1 * State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao 999078, P. R. China. , (China)
  • 2 † Faculty of Health Sciences, University of Macau, Macao 999078, P. R. China. , (China)
Type
Published Article
Journal
The American journal of Chinese medicine
Publication Date
Jan 01, 2017
Volume
45
Issue
7
Pages
1513–1536
Identifiers
DOI: 10.1142/S0192415X17500823
PMID: 28946767
Source
Medline
Keywords
License
Unknown

Abstract

Forsythiae Fructus, Lianqiao in Chinese, is one of the most fundamental herbs in Traditional Chinese Medicine. Both green Forsythia (GF) and ripe Forsythia (RF) are referred to Forsythiae Fructus in medicinal applications. In most cases, they are used without distinction. In this study, a metabolomics approach was performed to compare componential differences of two Forsythiae Fructus aqueous extracts subtypes. Principal component analysis (PCA) score plots from the UPLC-MS data showed clear separation between the two subtypes, indicating there are significant differences in the chemical components between GF and RF. Meanwhile, the anticancer activity of them was also compared. GF exhibited much stronger antitumor activity than RF against B16-F10 murine melanoma both in vitro and in vivo. 15 chemical compounds were identified as specific markers for distinguishing GF and RF. Among these marker compounds, forsythoside I, forsythoside A, forsythoside E and pinoresinol were demonstrated to be key important active compounds that account for the different anticancer efficacies of GF and RF. Our data suggest that GF and RF should be distinctively used in clinical applications, particularly in the anticancer formulas, in which GF should be preferentially prescribed.

Report this publication

Statistics

Seen <100 times